Indo National Ltd
NSE: NIPPOBATRY BSE: 504058
Incorporated in 1972, Indo National manufactures and markets batteries, torches, LED products, electrical accessories, mosquito bats, razors and blades[1]
₹344
52W: ₹255 — ₹589
PE 0 · Book ₹283 · +22% vs bookMarket Cap₹258 Cr
Stock P/E—Price to Earnings
ROCE1.79%Return on Capital
ROE4.75%Return on Equity
Div. Yield1.47%Face Value ₹5
Strengths
- +Company has been maintaining a healthy dividend payout of 133%
Weaknesses
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of 3.12% over past five years.
- −Company has a low return on equity of -1.12% over last 3 years.
- −Contingent liabilities of Rs.99.2 Cr.
- −Company might be capitalizing the interest cost
- −Earnings include an other income of Rs.7.20 Cr.
Shareholding Pattern
Promoters65.35%
FIIs0%
DIIs0%
Public34.65%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% | 65.35% |
| FIIs | 0% | 0.04%▲0.0 | 0%▼0.0 | 0% | 0.01%▲0.0 | 0%▼0.0 | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 34.65% | 34.61%▼0.0 | 34.66%▲0.0 | 34.65%▼0.0 | 34.64%▼0.0 | 34.64% | 34.62%▼0.0 | 34.65%▲0.0 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121.53 | 103.61 | 111.66 | 127.57 | 121.63 | 97.11 | 119.44 | 119.07 | 106.11 | 106.39 |
| Expenses | 117.69 | 102.9 | 108.16 | 126.29 | 120.12 | 98.42 | 116.09 | 113.56 | 111.33 | 111.57 |
| Operating Profit | 3.84 | 0.71 | 3.5 | 1.28 | 1.51 | -1.31 | 3.35 | 5.51 | -5.22 | -5.18 |
| OPM % | 3.16% | 0.69% | 3.13% | 1% | 1.24% | -1.35% | 2.8% | 4.63% | -4.92% | -4.87% |
| Net Profit | 1.88 | -0.79 | 1.01 | 2 | 0.63 | -2.63 | 1.62 | 2.68 | -6.62 | -8.08 |
| EPS ₹ | 2.51 | -1.05 | 1.35 | 2.67 | 0.84 | -3.51 | 2.16 | 3.57 | -8.83 | -10.77 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹451Cr, down 1.5% YoY. OPM at 0%.
Debt Position
Borrowings at ₹201Cr. Debt-to-equity ratio: 0.97x. Moderate leverage.
Capex Cycle
CWIP at ₹3Cr (2% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 65.35%.
Margin & Efficiency
ROCE declining from 20% (Mar 2015) to -2% (Mar 2026). Working capital days: -57.
Recent Announcements
- Corporate Action-Board approves Dividend 2d - Board approved FY26 audited results, recommended Rs3.75 dividend, and reappointed cost and internal auditors.
- Results For The Quarter And Year Ended 31St March 2026 2d
- Board Meeting Outcome for OUTCOME OF BOARD MEETING 2d - Board approved FY26 audited results, recommended Rs3.75 dividend, and reappointed cost and internal auditors.
- Board Meeting Outcome for OUTCOME OF BOARD MEETING 2d - Board approved FY26 audited results, recommended Rs.3.75 final dividend, and reappointed cost and internal auditors.
- Announcement under Regulation 30 (LODR)-Updates on Acquisition 13 May - On 13 May 2026, invested ₹80 lakh in Medcuore Medical Solutions, raising stake to 57.48%.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse